James William Burns - 23 Dec 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Chief Legal Officer
Signature: /s/ William Cook, as Attorney in Fact for James Burns
Issuer symbol: AGIO
Transactions as of: 23 Dec 2022
Net transactions value: -$73,963
Form type: 4
Filing time: 28 Dec 2022, 15:05:24 UTC
Previous filing: 03 Mar 2022
Next filing: 14 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+8,750	+58%	$0.000000	23,815	23 Dec 2022	Direct	F1
transaction	AGIO	Common stock	Tax liability	$73,963	-2,597	-11%	$28.48	21,218	28 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock units	Options Exercise	$0	-8,750	-100%	$0.000000^*	0	23 Dec 2022	Common stock	8,750		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 272 shares purchased through the Company's employee stock purchase plan.
F2	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3	The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022.